Hegseth announces new policy to test troops for low testosterone

What This is

• The Pentagon will begin adding testosterone screening to routine military health checks for service members.
• Hegseth framed the policy as a way to improve readiness and performance by restoring and optimizing “natural” capabilities.
• If a test shows low testosterone, medical staff may recommend treatment, but the service member will not be forced to take testosterone replacement therapy.
• Medical experts have raised concerns about blanket testing and the risk of overprescribing or inappropriate use of testosterone.
• The move fits with a broader Trump administration push to expand access to testosterone replacement therapy, alongside actions involving federal health agencies.
• The plan has drawn criticism as a distraction from other military priorities and raised questions about how the policy could affect those who decline treatment.

Why This Matters

• It shows what Pentagon leaders are choosing to define as “readiness,” which can steer budgets, medical policy, and military culture.
• Routine hormone testing can strain privacy and real consent, because troops may fear that refusing follow-up care could hurt assignments or promotions.
• Unclear rules for who is “low,” follow-up care, and how women are handled could make the program uneven and invite political and legal challenges.
• A large federal system promoting testosterone testing can shape wider U.S. debates over who should get these drugs and how tightly they should be regulated.